Annexin Pharmaceuticals AB (publ) (STO:ANNX)
14.50
+0.20 (1.40%)
At close: Mar 6, 2026
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 102.36 million as of March 6, 2026. Its market cap has decreased by -46.65% in one year.
Market Cap
102.36M
Enterprise Value
74.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.50
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 102.36M, an increase of 103.86%. That is a compound annual growth rate of 8.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 106.58M |
| Biovica International AB | 96.33M |
| Biosergen AB | 90.17M |
| Active Biotech AB | 118.89M |
| Scandinavian ChemoTech AB | 86.54M |
| Xbrane Biopharma AB | 121.49M |
| OncoZenge AB | 85.83M |
| Spago Nanomedical AB | 81.04M |